SPY424.25-1.01 -0.24%
DIA343.32-0.98 -0.28%
IXIC14,068.58-105.57 -0.74%

Canaccord Genuity Maintains Buy on ShockWave Medical, Raises Price Target to $202

Canaccord Genuity analyst William Plovanic maintains ShockWave Medical (NASDAQ:SWAV) with a Buy and raises the price target from $149 to $202.

05/11/2021 10:44
Canaccord Genuity analyst William Plovanic maintains ShockWave Medical (NASDAQ:SWAV) with a Buy and raises the price target from $149 to $202.